These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30777977)

  • 1.
    Salceanu SO; Hamada D; Ursu RG; Saad AA
    Indian J Ophthalmol; 2019 Mar; 67(3):424-426. PubMed ID: 30777977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected bacterial endophthalmitis following sustained-release dexamethasone intravitreal implant: a case report.
    Arıkan Yorgun M; Mutlu M; Toklu Y; Cakmak HB; Cağıl N
    Korean J Ophthalmol; 2014 Jun; 28(3):275-7. PubMed ID: 24882964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant coagulase-negative staphylococcal endophthalmitis following dexamethasone intravitreal implant.
    Mahalingam P; Topiwalla TT; Ganesan G
    Indian J Ophthalmol; 2017 Jul; 65(7):634-636. PubMed ID: 28724830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus lugdunensis endophthalmitis after intravitreal injection: a case series.
    Murad-Kejbou S; Kashani AH; Capone A; Ruby A
    Retin Cases Brief Rep; 2014; 8(1):41-4. PubMed ID: 25372206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWO CASES OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION.
    Esen E; Sizmaz S; Demircan N
    Retin Cases Brief Rep; 2016; 10(2):154-6. PubMed ID: 26426482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX).
    Cruz-Iñigo YJ; Klein K; Reddy RK
    Retin Cases Brief Rep; 2022 Mar; 16(2):170-173. PubMed ID: 31479011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
    Ekinci C; Kayıran A; Özdemir H
    Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical endophthalmitis after intraocular collamer lens implantation.
    Taneri S; Kießler S; Rost A; Schultz T; Elling M; Dick HB
    J Cataract Refract Surg; 2018 Dec; 44(12):1521-1523. PubMed ID: 30274842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
    Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery.
    Ng C; Chalam KV
    Eur J Ophthalmol; 2020 Sep; 30(5):NP29-NP31. PubMed ID: 31155929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Visual Outcomes of Culture-Proven Endophthalmitis Following Dexamethasone Intravitreal Implant.
    Stem MS; Todorich B; Yonekawa Y; Capone A; Williams GA; Ruby AJ
    JAMA Ophthalmol; 2017 Apr; 135(4):379-382. PubMed ID: 28208166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal dexamethasone in the management of acute endophthalmitis: a comparative retrospective study.
    Moisseiev E; Abbassi S; Park SS
    Eur J Ophthalmol; 2017 Jan; 27(1):67-73. PubMed ID: 27646336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics.
    Manning S; Ugahary LC; Lindstedt EW; Wubbels RJ; van Dissel JT; Jansen JTG; Gan I; van Goor AT; Bennebroek CA; van der Werf DJ; Ossewaarde-van Norel A; Mayland Nielsen CC; Tilanus M; van den Biesen PR; Schellekens PA; La Heij E; Faridpooya K; van Overdam K; Veckeneer M; van Meurs JC
    Acta Ophthalmol; 2018 Jun; 96(4):348-355. PubMed ID: 29214740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.
    Lalwani GA; Flynn HW; Scott IU; Quinn CM; Berrocal AM; Davis JL; Murray TG; Smiddy WE; Miller D
    Ophthalmology; 2008 Mar; 115(3):473-6. PubMed ID: 18067969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.